The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

NCT01007708 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

780

Enrollment

INDUSTRY

Sponsor class

Conditions

Onychomycosis

Interventions

DRUG: IDP-108
DRUG: Vehicle

Sponsor

Dow Pharmaceutical Sciences